Brief: Arctic Bioscience H1 Adjusted EBITDA NOK -13.6 Million
28/08/2025 07:00
Aug 28 (Reuters) - Arctic Bioscience H1 gross margin 33.4%. H1 gross profit NOK 5.8 million
Recent news on Arctic Bioscience AS
See all newsNorway's Arctic Bioscience Q1 sales rise 78% to record on America boost
Brief: Arctic Bioscience Q1 Adjusted EBITDA NOK -6.5 Million
Norway's Arctic Bioscience 2025 revenue falls due to product recall impact
Brief: Arctic Bioscience Q3 Adjusted EBITDA NOK -7.8 Million
Brief: Arctic Bioscience H1 Adjusted EBITDA NOK -13.6 Million